News
MRVI
8.58
+2.88%
0.24
Weekly Report: what happened at MRVI last week (0318-0322)?
Weekly Report · 3d ago
Implied FXH Analyst Target Price: $122
NASDAQ · 03/21 10:19
Weekly Report: what happened at MRVI last week (0311-0315)?
Weekly Report · 03/18 09:14
Bio-Techne and Qiagen had the biggest increase in short interest levels last month - Baird
Seeking Alpha · 03/13 18:01
Maravai LifeSciences Announces March 2024 Investor Conference Schedule
Barchart · 03/12 15:15
Analysts Offer Insights on Healthcare Companies: Maravai Lifesciences Holdings (MRVI) and R1 RCM (RCM)
TipRanks · 03/12 01:50
Commit To Purchase Maravai LifeSciences Holdings At $5, Earn 15% Using Options
NASDAQ · 03/11 19:20
Weekly Report: what happened at MRVI last week (0304-0308)?
Weekly Report · 03/11 09:14
Weekly Report: what happened at MRVI last week (0226-0301)?
Weekly Report · 03/04 09:14
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable
Maravai LifeSciences Holdings, Inc. Shares have gained 28% in the last month. The company's price-to-sales ratio of 3.8x matches the Life Sciences industry in the United States. The share price is down 45% in last 12 months. Maravai's revenue growth is expected to be similar to the broader industry. But the company's P/S ratio doesn't mean the stock is a good value.
Simply Wall St · 02/28 11:02
Weekly Report: what happened at MRVI last week (0219-0223)?
Weekly Report · 02/26 09:15
Buy Rating Affirmed for Maravai Lifesciences Amid Strong Financial Performance and Growth Outlook
In a report released on February 22, Robert W. Baird maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report), with a price target of $7.00. The company’s fourth-quarter revenue exceeded expectations and the company's initial revenue guidance for 2024 is promising.
TipRanks · 02/26 04:35
Health Care Sector Update for 02/23/2024: MODV, SEM, MRVI, ENVB
NASDAQ · 02/23 20:56
Nasdaq Edges Lower; AXT Shares Surge After Q4 Results
U.S. Stocks traded mixed toward the end of trading on Friday. The Dow traded up 0.23% to 39,158.52 while the NASDAQ fell 0.19%. The total number of active U.s. Oil rigs climbed by 6 rigs this week, Baker Hughes Inc reported. European shares closed higher while Asian markets closed mixed.
Benzinga · 02/23 20:06
Small-Cap Maravai LifeSciences' Q4 Outperforms Expectations, Analyst shows Optimism Around 2024 Guidance
Maravai LifeSciences Holdings Inc reported fourth-quarter 2023 revenue of $74.1 million. The company beat the consensus estimate of $64.38 million. Maravai introduced a full-year 2024 revenue guidance range of $265 million to $285 million.
Benzinga · 02/23 19:07
Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
MercadoLibre shares dipped 9.6% to $1,643.30 on Friday. The company reported quarterly earnings of $3.25 per share. AXT, Inc. Shares surged 74.4% after the company reported better-than-expected fourth-quarter results.
Benzinga · 02/23 19:07
BUZZ-U.S. STOCKS ON THE MOVE-Hyatt Hotels, Morningstar Inc, SunPower Corp
Wall Street's main indexes lost momentum on Friday. Dow Jones Industrial Average was up 0.28% at 39,179.23. Nvidia Corp briefly vaulted to over $2 trillion in market valuation for the first time. SunPower Corp, Hyatt Hotels, Morningstar Inc were among the biggest losers.
Reuters · 02/23 18:55
Maravai Lifesciences Up Over 60%, on Track for Record Percent Increase -- Data Talk
Maravai Lifesciences Holdings, Inc. Class A ( MRVI ) is currently at $8.21, up $3.10 or 60.69% month-to-date. Would be largest percent increase on record. Down 86.45% from its all-time closing high of $60.62.
Dow Jones · 02/23 18:29
Maravai LifeSciences Shares Rise 65% After 4Q Results
Shares of Maravai LifeSciences Holdings surged 65% to $8.41 after it reported a 64% fourth-quarter revenue decline. The company reported lower demand from Covid-19 vaccine manufacturers but better than forecasted demand for nucleic acid production products. Marvai projects 2024 revenue of $285 million.
Dow Jones · 02/23 18:15
CPOP, PMEC and ARIZ among mid-day movers
On the Move CPOP, PMEC and ARIZ among mid-day movers. Gainers: AXT (AXTI) and Maravai LifeSciences Holdings. Losers: Sequans Communications (SQNS) and ModivCare.
Seeking Alpha · 02/23 17:38
More
Webull provides a variety of real-time MRVI stock news. You can receive the latest news about Maravai Lifesciences Holdings, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About MRVI
Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enable the development of drug therapies, diagnostics and vaccines and to support research on human diseases. Its companies provide products and services in the fields of nucleic acid synthesis and biologics safety testing to various biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies. The Company operates through two segments. Nucleic Acid Production segment is focused on the manufacturing and sale of highly modified nucleic acid products to support the needs of customer research, therapeutic and vaccine programs. The segment also provides research products for labeling and detecting proteins in cells and tissue samples. Biologics Safety Testing segment is focused on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities.